Lacosamide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69367-350 -
Package NDC
69367-350-60 -
Application number
ANDA205237 -
SPL ID
0f5e4e3e-9948-4a0a-9a6e-810714eeece9 -
SPL set ID
ecb8b33e-7cbd-4f5e-9fe9-e72dff9bcb86 -
UNII
563KS2PQY5 -
RxCUI
809987 -
RxCUI
809992 -
RxCUI
809996 -
RxCUI
810000
What the source publishes
- Labeler
- Westminster Pharmaceuticals, LLC
- Active ingredients
- Lacosamide
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Lacosamide",
"splId": "0f5e4e3e-9948-4a0a-9a6e-810714eeece9",
"labels": [
{
"setId": "ecb8b33e-7cbd-4f5e-9fe9-e72dff9bcb86",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ecb8b33e-7cbd-4f5e-9fe9-e72dff9bcb86",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ecb8b33e-7cbd-4f5e-9fe9-e72dff9bcb86"
}
],
"routes": [
"ORAL"
],
"labeler": "Westminster Pharmaceuticals, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69367-350-60)",
"package_ndc": "69367-350-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20230710"
}
],
"productId": "69367-350_0f5e4e3e-9948-4a0a-9a6e-810714eeece9",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "69367-350",
"deaSchedule": "CV",
"genericName": "Lacosamide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LACOSAMIDE",
"strength": "150 mg/1"
}
],
"applicationNumber": "ANDA205237",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230710",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"upc": [
"0369367351607",
"0369367350600",
"0369367348607",
"0369367349604"
],
"unii": [
"563KS2PQY5"
],
"rxcui": [
"809987",
"809992",
"809996",
"810000"
],
"spl_set_id": [
"ecb8b33e-7cbd-4f5e-9fe9-e72dff9bcb86"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"Westminster Pharmaceuticals, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69367-350_0f5e4e3e-9948-4a0a-9a6e-810714eeece9"